NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

W hen BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some ...

HHS officials are citing an extensive list of studies purported to document harms caused by mRNA vaccines as scientific ...

"People are going to die because we're cutting short funding for this technology," Dr. Jerome Adams said in an interview with ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

The fate of an important breakthrough in cancer immunotherapy treatment remains in the balance following an announcement ...

The U.S. Department of Health and Human Services announced on Tuesday that it will cancel $500 million worth of projects ...

The government’s cancellation of almost $500 million in contracts involving mRNA vaccines could halt progress on cancer ...

President Trump’s laissez-faire approach is notable, given that the development of the Covid vaccine was seen as one of his ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

New messenger RNA vaccines to fight the coronavirus are based on a technology that could transform medicine. Next up: sickle cell and HIV. On December 23, as part of a publicity push to encourage ...